Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer

Figures & Tables

Patient age	HIV viral load (copies/ml)	CD4+ (cell/ml)	Pap cytology¹	HPV type²
Group I³
45	< 50	744	I and II	90 (LR)
30	< 50	726	I and II	ND
23	5,840	655	I	11 (LR)
30	< 50	602	I and II	97 (LR)
17	90,800	580	I and II	51 (HR)
42	< 50	521	I	ND
44	< 50	506	I	66 (HR)
50	400	503	I and II	16 (HR)
35	< 50	485	I	16 (HR)
27	< 50	481	I and II	51 (HR)
37	< 50	410	IV	51 (HR)
42	< 50	405	I	11 (LR)
60	57	388	I	58 (HR)
29	< 50	380	I and II	70 (LR)
31	4,940	364	I and II	ND
Group II³
35	< 50	317	I and II	ND
35	< 50	294	IV	ND
24	1,170	282	I and II	ND
30	< 50	280	III	54 (LR)
42	< 50	258	I and II	102 (LR)
49	< 50	255	I and II	6 (LR)
35	< 50	208	I	84 (LR)
32	369	180	I	51(HR)
36	13,900	175	I and II	51 (HR)
37	< 50	161	III	81 (LR)
28	67	160	I and II	ND
24	74,620	146	I and II	ND
51	< 50	132	III	51 (HR)
37	73	127	IV	81 (LR)
48	5560	104	I and II	6 (LR)
43	< 50	103	I and II	86 (LR)
37	ND	102	I	56 (HR)
31	< 50	76	III	52 (HR)
23	> 100,000	70	I and II	6 (LR)
34	822	65	III	58 (HR)
63	451	63	I and II	ND
44	5,140	60	I and II	51 (HR)
25	95200	30	I and II	81 (LR)
41	ND	22	III	33(HR)
31	> 100,000	16	I and II	70 (LR)